Literature DB >> 1483487

Influence of food on the tyramine pressor effect during chronic moclobemide treatment of healthy volunteers.

C Audebert1, O Blin, S Monjanel-Mouterde, P Auquier, A M Pedarriosse, J Dingemanse, A Durand, J P Cano.   

Abstract

An open study was carried out to examine the effect of moclobemide, a new antidepressant reversible inhibitor of MAO-A, on the pressor response induced by oral tyramine added to meals of different lipid and protein composition, and to correlate the blood pressure increase in the tyramine test with that obtained during an exercise test. Eight healthy volunteers of both sexes participated in the study. A tyramine sensitivity and an exercise test were performed beforehand. Subjects were included if, under fasting condition, their systolic blood pressure (SBP) increased by more than 30 mmHg after administration of 400 or 600 mg tyramine. Exercise tests were performed to determine the grade of effort that corresponded to a rise in SBP of 30 mmHg. Subjects received moclobemide 600 mg/d. Starting on Day 7, each subject consumed a standardized meal (52 g lipids, 43 g proteins, 86 g carbohydrates) just before taking moclobemide. Tyramine was added to these meals in daily increasing doses of 50, 100, 150...mg until an increase in SBP > or = 30 mmHg was obtained. On moclobemide treatment, an average dose of 250 mg tyramine (range 150-400 mg) increased SBP by 36.6 mmHg. The time to reach peak SBP was longer (175 min) than in the fasting condition before the trial (40.6 min).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1483487     DOI: 10.1007/bf02285092

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  18 in total

Review 1.  Multiple forms of monoamine oxidase: fact and artefact.

Authors:  M D Houslay; K F Tipton
Journal:  Life Sci       Date:  1976-08-15       Impact factor: 5.037

2.  The action of sympathomimetic amines in animals treated with reserpine.

Authors:  J H BURN; M J RAND
Journal:  J Physiol       Date:  1958-12-04       Impact factor: 5.182

3.  Pharmacokinetics of moclobemide after single and multiple oral dosing with 150 milligrams 3 times daily for 15 days.

Authors:  T W Guentert; G Tucker; A Korn; J P Pfefen; P Haefelfinger; M P Schoerlin
Journal:  Acta Psychiatr Scand Suppl       Date:  1990

4.  Oral tyramine pressor test and the safety of MAO inhibitor drugs.

Authors:  R Schulz; P R Bieck
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

5.  Pressor response of oral tyramine in healthy men given amiflamine and placebo.

Authors:  M Grind; B Siwers; C Graffner; G Alván; L L Gustafsson; J Helleday; J E Lindgren; S Ogenstad; H Selander
Journal:  Clin Pharmacol Ther       Date:  1986-08       Impact factor: 6.875

6.  Efficacy of reversible inhibitors of monoamine oxidase-A in various forms of depression.

Authors:  Y Lecrubier; J D Guelfi
Journal:  Acta Psychiatr Scand Suppl       Date:  1990

7.  Moclobemide and clomipramine in the treatment of depression. A randomized clinical trial.

Authors:  J K Larsen; P Holm; P L Mikkelsen
Journal:  Acta Psychiatr Scand       Date:  1984-09       Impact factor: 6.392

8.  Effects of caroxazone, a reversible monoamine oxidase inhibitor, on the pressor response to oral tyramine in man.

Authors:  A Martini; L Bonollo; F B Nicolis; R Sega; A Palermo
Journal:  Br J Clin Pharmacol       Date:  1981-06       Impact factor: 4.335

9.  Tyramine studies and the safety of MAOI drugs.

Authors:  G M Simpson; K White
Journal:  J Clin Psychiatry       Date:  1984-07       Impact factor: 4.384

Review 10.  On tyramine, food, beverages and the reversible MAO inhibitor moclobemide.

Authors:  M Da Prada; G Zürcher; I Wüthrich; W E Haefely
Journal:  J Neural Transm Suppl       Date:  1988
View more
  5 in total

1.  Pressor response to oral tyramine and monoamine oxidase inhibition during treatment with ralfinamide (NW-1029).

Authors:  Andrea F D Di Stefano; Milko Massimiliano Radicioni; Antonio Rusca
Journal:  Neurotox Res       Date:  2012-08-08       Impact factor: 3.911

2.  Pressor response to oral tyramine during co-administration with safinamide in healthy volunteers.

Authors:  Andrea Francesco Daniele Di Stefano; Antonio Rusca
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-08-19       Impact factor: 3.000

Review 3.  The Prescriber's Guide to the MAOI Diet-Thinking Through Tyramine Troubles.

Authors:  Vincent Van den Eynde; Peter Kenneth Gillman; Barry B Blackwell
Journal:  Psychopharmacol Bull       Date:  2022-05-31

4.  Comparison of the effects of moclobemide and selegiline on tyramine-evoked mydriasis in man.

Authors:  P Bitsios; R W Langley; S Tavernor; K Pyykkö; M Scheinin; E Szabadi; C M Bradshaw
Journal:  Br J Clin Pharmacol       Date:  1998-06       Impact factor: 4.335

5.  Monoamine Oxidase Inhibitors (MAOIs) in Psychiatric Practice: How to Use them Safely and Effectively.

Authors:  Samuel R Chamberlain; David S Baldwin
Journal:  CNS Drugs       Date:  2021-07-09       Impact factor: 5.749

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.